Literature DB >> 35422520

Alirocumab induces plaque regression.

Irene Fernández-Ruiz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35422520     DOI： 10.1038/s41569-022-00706-9

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial.

Authors:  Lorenz Räber; Yasushi Ueki; Tatsuhiko Otsuka; Sylvain Losdat; Jonas D Häner; Jacob Lonborg; Gregor Fahrni; Juan F Iglesias; Robert-Jan van Geuns; Anna S Ondracek; Maria D Radu Juul Jensen; Christian Zanchin; Stefan Stortecky; David Spirk; George C M Siontis; Lanja Saleh; Christian M Matter; Joost Daemen; François Mach; Dik Heg; Stephan Windecker; Thomas Engstrøm; Irene M Lang; Konstantinos C Koskinas
Journal:  JAMA       Date:  2022-05-10       Impact factor: 157.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.